Thanks for the balance. I believe that Aspire has enjoyed the relationship, but maybe not now if suddenly CTIX accessed the final amount in one order after the conference. If Aspire was at the meeting, then I would say this is less likely.
I agree they have sold in ways to not tank in the past, but again, if accessed in one final order, that would change their previous strategy.
Maybe it was completely due to the lack of disconnect that I and many may have seen in Leo's comments over the past few months and then where the conference call put the company. Itt was in bad taste to hint at uplisting very soon after the FDA asked for data, and to be communicating about the shorts.
Market Data 
Markets 
AI
